TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Unimedic Pharma Holding AB
Closing information (x1000 DKK)
| Closing information | 2023/12 | 2022/12 | 2021/12 | 
| Turnover | 1,823 | 2,668 | 2,705 | 
| Financial expenses | 2,913 | 1,135 | 971 | 
| Earnings before taxes | -2,983 | -2,094 | -1,327 | 
| EBITDA | -367 | -1,038 | -381 | 
| Total assets | 54,658 | 54,289 | 55,391 | 
| Current assets | 234 | 2,088 | 846 | 
| Current liabilities | 4,062 | 5,073 | 9,062 | 
| Equity capital | 506 | 212 | 363 | 
| - share capital | 202 | 200 | 218 | 
| Employees (average) | 0   | 0   | 0 | 
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Solvency | 0.9% | 0.4% | 0.7% | 
| Turnover per employee | |||
| Profit as a percentage of turnover | -163.6% | -78.5% | -49.1% | 
| Return on assets (ROA) | -0.1% | -1.8% | -0.6% | 
| Current ratio | 5.8% | 41.2% | 9.3% | 
| Return on equity (ROE) | -589.5% | -987.7% | -365.6% | 
| Change turnover | -859 | 182 | 646 | 
| Change turnover % | -32% | 7% | 31% | 
| Chg. No. of employees | 0   | 0 | -3 | 
| Chg. No. of employees % | -100% | 
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 | 
| Total value of public sale | 0   | 0   | 0 | 
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.
 
         
                    